BioTechnology
For more than 6,000 years, biotechnology has been quietly working in the background of civilizations, creating and preserving useful food products, such as bread, cheese, wine, and dairy, making our lives healthier and more manageable, daily. Biotechnology, or Bio-Tech, is simply technology based on biology – it harnesses these cellular and biomolecular processes to develop products and technologies to feed, fuel, and heal our world. Modern biotechnology provides breakthrough products and technologies to counter debilitating and rare diseases, reduce our environmental footprint, feed the hungry, use less and cleaner energy, and have safer, cleaner and more efficient industrial manufacturing processes.
Today, there are more than 250 biotechnology health care products and vaccines available to patients (many for previously untreatable diseases), more than 13.3 million farmers around the world using agricultural biotechnology, and more than 50 biorefineries being built across North America. Bio-Tech is working hard to solve our society’s most pressing challenges.
A field with a long history and such recent technological advancements still has its issues. Trends in AI, Big Data, and precision medicine are attempting to improve and personalize patient care and experience, but since the COVID pandemic, Bio-Tech companies have struggled with a lacking workforce unable to meet the incredibly high demand. Furthermore, many Bio-Tech startups are deemed too risky for investors with the regulatory uphill battle many face from the very beginning, strapping new companies for much-needed early-stage capital.
At reesmarx, we have been helping Bio-Tech companies in recruitment and risk management, addressing these issues in the industry and solving nuanced needs in a complex field. Specifically, we have been helping Bio-Tech companies find and hire highly niched Bio-Tech teams across the US and all over the globe while minimizing their risks.
Read on how reesmarx is helping Bio-Tech companies to optimize their resource challenges by hiring wisely, streamlining revenue generation and operations, and growing to new levels.
Today, there are more than 250 biotechnology health care products and vaccines available to patients (many for previously untreatable diseases), more than 13.3 million farmers around the world using agricultural biotechnology, and more than 50 biorefineries being built across North America. Bio-Tech is working hard to solve our society’s most pressing challenges.
A field with a long history and such recent technological advancements still has its issues. Trends in AI, Big Data, and precision medicine are attempting to improve and personalize patient care and experience, but since the COVID pandemic, Bio-Tech companies have struggled with a lacking workforce unable to meet the incredibly high demand. Furthermore, many Bio-Tech startups are deemed too risky for investors with the regulatory uphill battle many face from the very beginning, strapping new companies for much-needed early-stage capital.
